LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis

  • 0Department of Bioscience, Manipal University Jaipur, University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, 303007, India.

|

|

Summary

This summary is machine-generated.

Lactate dehydrogenase A (LDHA) overexpression in breast cancer correlates with poor survival and metastasis. Natural compounds like Withaferine A show potential as LDHA inhibitors for targeted therapy.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biochemistry

Background

  • Breast cancer heterogeneity necessitates understanding molecular drivers like Lactate Dehydrogenase A (LDHA) expression.
  • The role of non-coding RNAs in regulating LDHA and their prognostic significance in breast cancer remains largely unexplored.

Purpose Of The Study

  • To investigate the prognostic implications of LDHA expression in breast cancer.
  • To explore the regulatory network of LDHA, including non-coding RNAs and their association with tumor-infiltrating immune cells.
  • To identify potential therapeutic agents targeting LDHA.

Main Methods

  • Bioinformatic analysis of gene expression and survival data from public repositories (TIMER 2.0, UALCAN, TISIDB, Breast Cancer Gene Expression Miner).
  • Exploration of the relationship between LDHA, non-coding RNAs (e.g., TMPO-AS1, miR-383-5p), and tumor-infiltrating immune cells using GSCA and TISIDB.
  • Molecular docking simulations using Auto Dock Tools to assess the binding affinity of withanolides and an inhibitor (LDH-IN-1) with LDHA.

Main Results

  • LDHA overexpression is linked to reduced recurrence-free survival, overall survival, and distant metastasis-free survival in breast cancer patients.
  • Invasive breast cancer exhibits overexpression of LDHA, HIF-1α, and TMPO-AS1, alongside downregulation of miR-383-5p, correlating with poor prognosis.
  • Withanolides (Withaferine A, Withanolide D) demonstrated high binding affinity to LDHA, suggesting potential as small-molecule inhibitors.

Conclusions

  • LDHA overexpression serves as a negative prognostic biomarker in breast cancer.
  • The LDHA/HIF-1α/TMPO-AS1 axis and miR-383-5p dysregulation are implicated in breast cancer progression and immune microenvironment modulation.
  • Withanolides represent promising candidates for developing novel LDHA-targeted therapies for breast cancer.

Keywords:

Related Concept Videos

lncRNA - Long Non-coding RNAs 02:39

8.5K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs 01:22

3.0K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Abnormal Proliferation 02:23

4.5K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...